Beta Blocker Use in Slow Atrial Flutter with Pacemaker

Introduction to Beta Blocker Therapy

• The American Heart Association recommends beta blockers as safe and effective for rate control in patients with atrial flutter who have a pacemaker, as the pacemaker provides protection against bradycardia and heart block 1, 2

First-Line Beta Blocker Selection

• The American College of Cardiology recommends metoprolol as the preferred beta blocker for rate control in atrial flutter, with dosing options including 2.5-5 mg IV bolus over 2 minutes, up to 3 doses, and 25-200 mg twice daily (tartrate) or 50-400 mg once or twice daily (succinate/extended-release) 3

Clinical Decision Algorithm Based on Cardiac Function

• For patients with preserved left ventricular function (LVEF ≥40%), beta blockers achieve rate control targets in 70% of patients as monotherapy, and either beta blockers or non-dihydropyridine calcium channel blockers are acceptable first-line options 3
• For patients with heart failure or reduced LVEF (<40%), beta blockers are mandatory first-line therapy, and non-dihydropyridine calcium channel blockers must be avoided entirely as they can exacerbate hemodynamic compromise 3, 4

Rate Control Targets in Atrial Flutter

• The European Society of Cardiology recommends target heart rates of <110 bpm at rest as an initial lenient target, and 60-80 bpm at rest and 90-115 bpm during moderate exercise for symptomatic patients 3
• Higher doses of beta blockers are frequently required in atrial flutter compared to atrial fibrillation to achieve adequate rate control 5

Alternative Approach: Rhythm Control Strategy

• The Heart Rhythm Society recommends catheter ablation of the cavotricuspid isthmus (CTI) as a preferred approach to long-term pharmacological therapy, with a success rate of >90% 1, 7